Seeking Alpha
14 Oct 2026, 05:03 UTC · 3h ago
Eastman Chemical: The Market Is Overreacting To Suspected Downside
Impact · against what's priced in
Eastman Chemical (EMN) shows strong operational momentum and an attractive valuation based on normalized earnings potential. While the report is bullish, much of the growth data is already reflected in the current market sentiment, leaving the catalyst tied to a multiple rerating.
- EMN+0.40
No priced-in read yet
- In context
Operational growth in 2Q26, with AEPS up 23% and EBIT up 16%, combined with a normalized EPS potential of $8, suggests the current 7-8x P/E multiple is undervalued relative to a $104 fair value.
Read from the article alone
Top 1 mover · tap to explore
